C12N 2760/18843
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2760/18843 (Viral genome or elements thereof as genetic vector) appears on 55 US grants and 132 published applications in this corpus.
Search patents in C12N- Granted patents
- 55
- Published applications
- 132
- Assignees
- 65
- Inventors
- 230
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 6 |
| 2003 | 2 | 5 |
| 2004 | 3 | 6 |
| 2005 | 0 | 6 |
| 2006 | 2 | 4 |
| 2007 | 2 | 3 |
| 2008 | 3 | 4 |
| 2009 | 2 | 4 |
| 2010 | 2 | 8 |
| 2011 | 0 | 4 |
| 2012 | 2 | 3 |
| 2013 | 1 | 2 |
| 2014 | 0 | 2 |
| 2015 | 3 | 3 |
| 2016 | 1 | 5 |
| 2017 | 2 | 4 |
| 2018 | 1 | 4 |
| 2019 | 2 | 4 |
| 2020 | 4 | 7 |
| 2021 | 5 | 4 |
| 2022 | 2 | 10 |
| 2023 | 2 | 8 |
| 2024 | 5 | 6 |
| 2025 | 6 | 16 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing induced pluripotent stem cells20 Jan 2026US 12,529,035 B1National University Corporation Kobe University
- Method for selecting cancer patients for whom combination therapy with retinoid and cancer therapeutic agent is effective, and combination medicament with retinoid and cancer therapeutic agent13 Jan 2026US 12,521,358 B2RaQualia Pharma Inc.
- Erythrocyte removal device, mononuclear cell collector, cell culture device, cell culture system, cell culture method, and mononuclear cell collection method28 Oct 2025US 12,454,681 B2I Peace, Inc.
- Method for producing immune cells and use thereof7 Oct 2025US 12,435,117 B2Korea Research Institute of Bioscience and Biotechnology
- Method for preparing induced pluripotent stem cells by reprogramming somatic cells26 Aug 2025US 12,398,374 B2Zhejiang Huode Bioengineering Company Limited
- Vaccine with reduced anti-vector antigenicity24 Sep 2026US 2026/0284178 A1
- Production method for induced pluripotent stem cells27 Aug 2026US 2026/0250638 A1Sekisui Chemical Co., Ltd.
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector27 Aug 2026US 2026/0250709 A1Repli-Tech Co., Ltd.
- Composition and Use Method Therefor14 May 2026US 2026/0131027 A1Nanjing Reju Therapeutics, Co., Ltd.
- Production method for induced pluripotent stem cells25 Dec 2025US 2025/0388870 A1Sekisui Chemical Co., Ltd.
Most cited
By later US patents
- Infectious Sindbis virus vectors121US 5,217,879 AWashington University · 1993
- Paramyxovirus vectors used for transfer of foreign genes13US 6,746,860 B1DNAVEC Research Inc. · 2004
- Process for preparation of cytokines using Sendai virus expression system12US 6,514,728 B1Nippon Biocaptal Limited · 2003
- Negative strand RNA viral vector having autonomous replication capability12US 6,645,760 B2DNAVEC Research Inc. · 2003
- Negative strand RNA viral vector having autonomous replication capability12US 6,723,532 B2DNAVEC Research Inc. · 2004